Cyclin-dependent kinase inhibitors 1A and 2A (CDKN1A and CDKN2A) have been identified as ferroptosis-related genes in recent studies and can be regarded as biomarkers that influence the tumor microenvironment [43,44,45]. Here, CDKN1A is linked to neoplasm.